Inergetics, a developer of nutritional supplements, announced that the company will be presenting Martha Stewart Essentials, a line of whole food-based vitamin supplements developed in tandem with Martha Stewart herself at Cardinal Health's Retail Business Conference.
The Food and Drug Administration on Wednesday announced approval for Zydelig (idelalisib) to treat patients with chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.
Walgreens on Tuesday announced the new Balance Rewards for healthy choices initiatives, which is aimed at helping participants modify behavior risk factors associated with the nation's most pressing public health issues.
Sandoz on Monday announced an agreement with Anacor Pharmaceuticals to obtain exclusive rights to commercialize Kerydin (tavaborole) topical solution, 5%, through its branded dermatology business, PharmaDerm.
Teva Pharmaceutical Industries on Monday announced that its acquistion of Labrys has been completed. The acquisition brings to Teva LBR-101, which is currently in phase-2b clinical trials for prevention of chronic and episodic migraines.
The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.
According to a recent study published in Pediatrics, use of milliliters as a dosage measurement unit, as opposed to teaspoons and tablespoons, cut down significantly on medication dosing errors when parents administered medicines to their children.
Mylan on Thursday announced that the U.S. District Court for the district of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline in relation to paroxetine CR, the generic version of GSK's Paxil CR.